Skip to content

Author

Christopher M. McKinney

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Reduced-Intensity Haploidentical Bone Marrow Transplantation in Children with Severe Sickle Cell Disease: BMT CTN 1507.

This is a multi-center, single-arm, phase-II, trial (NCT03263559) of haploidentical bone marrow transplant (BMT) for children with severe sickle cell disease (SCD). Eligible participants were children 5.00 - 14.99 years of age with stroke (silent or overt), abnormal transcranial Doppler cerebral arterial velocity > 200...

Mark C. Walters, Adetola A. Kassim, M. Eapen et al. · 0 citations
Open access Oct 2026

National Alliance of Sickle Cell Disease Consensus Recommendations for Gene Therapy Implementation.

Gene therapy for sickle cell disease (SCD) is rapidly advancing, with approved products and others in development, creating an urgent need to define how treatment centers can safely and effectively deliver this care. The National Alliance of Sickle Cell Centers (NASCC) conducted a modified Delphi consensus process invo...

Alexis Leonard, Sharl Azar, Christopher M. McKinney et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.